Effects of Rapid Genetic Counseling and Testing in Newly Diagnosed Breast Cancer Patients

Plain-language summary

This study examined the effects of rapid genetic counseling and testing (RGCT) in newly diagnosed breast cancer patients. It was open to newly diagnosed patients with a 10% or higher chance of carrying a BRCA1/2 gene mutation. Run by The Netherlands Cancer Institute, it was a study without an assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

The Netherlands Cancer Institute

Intervention

RGCT

Start date

11/1/2008

Estimated completion

3/1/2012

Countries

Netherlands

Related genes

Locations

• Amsterdam, Netherlands

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* newly diagnosed breast cancer
* 10% or higher chance of carrying BRCA1/2 gene mutation

Exclusion Criteria:

* age \<18 years
* does not speak Dutch